Recursion Pharmaceuticals Stock Technical Analysis
| RXRX Stock | USD 3.53 0.07 2.02% |
As of the 20th of February, Recursion Pharmaceuticals holds the Coefficient Of Variation of (1,332), variance of 18.81, and Risk Adjusted Performance of (0.05). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Recursion Pharmaceuticals, as well as the relationship between them.
Recursion Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Recursion, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to RecursionRecursion | Build AI portfolio with Recursion Stock |
Recursion Pharmaceuticals Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 7.0 | Buy | 8 | Odds |
Most Recursion analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Recursion stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Recursion Pharmaceuticals, talking to its executives and customers, or listening to Recursion conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Recursion Pharmaceuticals. Anticipated expansion of Recursion directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Recursion Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.84) | Revenue Per Share | Quarterly Revenue Growth (0.80) | Return On Assets | Return On Equity |
Understanding Recursion Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Recursion's accounting equity. The concept of intrinsic value - what Recursion Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Recursion Pharmaceuticals' price substantially above or below its fundamental value.
It's important to distinguish between Recursion Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Recursion Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Recursion Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Recursion Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Recursion Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Recursion Pharmaceuticals.
| 11/22/2025 |
| 02/20/2026 |
If you would invest 0.00 in Recursion Pharmaceuticals on November 22, 2025 and sell it all today you would earn a total of 0.00 from holding Recursion Pharmaceuticals or generate 0.0% return on investment in Recursion Pharmaceuticals over 90 days. Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by i... More
Recursion Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Recursion Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Recursion Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 20.15 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 7.87 |
Recursion Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Recursion Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Recursion Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Recursion Pharmaceuticals historical prices to predict the future Recursion Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | 6.42 |
Recursion Pharmaceuticals February 20, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | 6.43 | |||
| Mean Deviation | 3.39 | |||
| Coefficient Of Variation | (1,332) | |||
| Standard Deviation | 4.34 | |||
| Variance | 18.81 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | 6.42 | |||
| Maximum Drawdown | 20.15 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 7.87 | |||
| Skewness | 0.7985 | |||
| Kurtosis | 0.4183 |
Recursion Pharmaceuticals Backtested Returns
Recursion Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.061, which implies the firm had a -0.061 % return per unit of risk over the last 3 months. Recursion Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Recursion Pharmaceuticals' Coefficient Of Variation of (1,332), variance of 18.81, and Risk Adjusted Performance of (0.05) to confirm the risk estimate we provide. The company holds a Beta of -0.0523, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Recursion Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Recursion Pharmaceuticals is likely to outperform the market. At this point, Recursion Pharmaceuticals has a negative expected return of -0.26%. Please make sure to check Recursion Pharmaceuticals' skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if Recursion Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.44 |
Average predictability
Recursion Pharmaceuticals has average predictability. Overlapping area represents the amount of predictability between Recursion Pharmaceuticals time series from 22nd of November 2025 to 6th of January 2026 and 6th of January 2026 to 20th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Recursion Pharmaceuticals price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Recursion Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.21 |
Recursion Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Recursion Pharmaceuticals Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Recursion Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Recursion Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Recursion Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Recursion Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Recursion Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Recursion Pharmaceuticals. By analyzing Recursion Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Recursion Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Recursion Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Net Debt To EBITDA | 1.11 | 1.14 | 1.31 | 1.83 | Intangibles To Total Assets | 0.14 | 0.33 | 0.3 | 0.32 |
Recursion Pharmaceuticals February 20, 2026 Technical Indicators
Most technical analysis of Recursion help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Recursion from various momentum indicators to cycle indicators. When you analyze Recursion charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | 6.43 | |||
| Mean Deviation | 3.39 | |||
| Coefficient Of Variation | (1,332) | |||
| Standard Deviation | 4.34 | |||
| Variance | 18.81 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | 6.42 | |||
| Maximum Drawdown | 20.15 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 7.87 | |||
| Skewness | 0.7985 | |||
| Kurtosis | 0.4183 |
Recursion Pharmaceuticals February 20, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Recursion stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.16 | ||
| Daily Balance Of Power | 0.12 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 3.26 | ||
| Day Typical Price | 3.35 | ||
| Price Action Indicator | 0.30 | ||
| Market Facilitation Index | 0.56 |
Additional Tools for Recursion Stock Analysis
When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.